Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ENTXENTX
9 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ENTERA BIO LTD

No. Bank of America exited its ENTX (Entera Bio) position in Q2 2026. Its Q1 2026 13F listed 12,000 shares worth $13,320. Bank of America first reported ENTX in Q2 2024 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5,520

Total Shares Change

-3,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.77
0
2026-Q1
Decreased
12,000
-20.0%
$13,3200.0%$1.11
0
2025-Q4
Decreased
15,000
-28.6%
$29,1000.0%$1.94
0
2025-Q3
Decreased
21,000
-10.4%
$40,3200.0%$1.92
0
2025-Q2
Decreased
23,430
-24.4%
$44,5170.0%$1.90
0
2025-Q1
Increased
30,987
+267.6%
$52,6780.0%$1.70
23
2024-Q4
Unchanged
8,430
0.0%
$17,8720.0%$2.12
0
2024-Q3
Increased
8,430
+181.0%
$16,0170.0%$1.90
20
2024-Q2
New
3,000
-
$5,5200.0%$1.84
24

Other major holders of ENTX: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used